financetom
Business
financetom
/
Business
/
Interactive Brokers Daily Average Revenue Trades Rise 46% YOY in October
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Interactive Brokers Daily Average Revenue Trades Rise 46% YOY in October
Nov 4, 2024 11:17 AM

01:49 PM EDT, 11/01/2024 (MT Newswires) -- Interactive Brokers Group ( IBKR ) said Friday its daily average revenue trades in October rose 46% year over year to about 2.82 million.

Ending client equity of $540.0 billion was 47% higher from previous year, while client accounts grew 28% to 3.2 million, the company said.

The average commission per cleared commissionable order during the month was $2.86, including exchange, clearing and regulatory fees, the company added.

Interactive Brokers ( IBKR ) shares were 0.7% higher in recent trading.

Price: 153.61, Change: +1.03, Percent Change: +0.68

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With MMTec Stock Thursday?
What's Going On With MMTec Stock Thursday?
Dec 12, 2024
MMTec, Inc. ( MTC ) shares are trading lower on Thursday after the company announced a 1-for-8 reverse stock split. The Details: The reverse stock split, approved by the board of directors on Nov. 21, 2024, will take effect on Dec. 18 at market open. It will reduce the authorized number of shares of the company’s common stock from 5,000,000,000...
--Apple Nears Switch to In-House Chips for iPhones From Broadcom, Bloomberg Reports
--Apple Nears Switch to In-House Chips for iPhones From Broadcom, Bloomberg Reports
Dec 12, 2024
01:21 PM EST, 12/12/2024 (MT Newswires) -- Price: 248.60, Change: +2.10, Percent Change: +0.85 ...
Keros Therapeutics Prospects Still Strong Despite Cibotercept Hurdles, Wedbush Says
Keros Therapeutics Prospects Still Strong Despite Cibotercept Hurdles, Wedbush Says
Dec 12, 2024
01:24 PM EST, 12/12/2024 (MT Newswires) -- Keros Therapeutics' ( KROS ) efforts to develop new treatments for pulmonary arterial hypertension remain potentially viable despite the company announcing Thursday that it voluntarily halted dosing in the 3 mg/kg and 4.5 mg/kg arms of its phase 2 trial for cibotercept, analysts at Wedbush wrote in a research note Thursday. The company's...
Market Chatter: Apple Nears Switch to In-House Chips From Broadcom
Market Chatter: Apple Nears Switch to In-House Chips From Broadcom
Dec 12, 2024
01:24 PM EST, 12/12/2024 (MT Newswires) -- Apple ( AAPL ) is planning to switch to a homegrown chip for Bluetooth and Wi-Fi connections for its devices next year, a move that will replace some parts provided by Broadcom ( AVGO ) , Bloomberg reported Thursday, citing people familiar with the matter. Like Apple's ( AAPL ) other in-house chips,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved